B.Grimm Pharma, the leading manufacturer and distributor of pharmaceuticals, nutraceuticals, and cosmeceuticals in Thailand, is part of B.Grimm’s Healthcare business, one of the three main pillars alongside B.Grimm Power, the listed company, and B.Grimm Industrial businesses. Offering holistic healthcare solutions covering every aspect of the pharmaceutical industry, B.Grimm Pharma has signed a Sole Distribution Agreement with Inter Mohosot Co., Ltd. to enhance access to quality medications in Cambodia. Inter Mohosot will serve as the distribution partner for B.Grimm Pharma’s products, covering various therapeutic areas, including Cardiovascular System, Central Nervous System, and Musculoskeletal System. The collaboration will involve over 16 medications addressing common conditions such as depression, epilepsy, hypertension, diabetes, neuropathic pain, and etc.
This partnership aims to provide many patients in Cambodia with fair access to quality treatments, starting in January 2025 at public hospitals, private clinics, and pharmacies in Phnom Penh and surrounding provinces.
Mr. Kittisak Dumrongtananurak, Head of B.Grimm Pharma, stated, “With the growing demand for medications in Cambodia, B.Grimm Pharma is ready to meet the needs for quality pharmaceuticals and healthcare products. We are pleased to partner with Inter Mohosot, a trusted company with deep insights into the pharmaceutical business in Cambodia. This collaboration will not only support our expansion in the Cambodian market but also align with our goal to enhance access to quality medications for a broader population beyond Thailand.”
Mr. Borey Koy, CEO of Inter Mohosot Co. Ltd., expressed enthusiasm for the collaboration: “We are excited to partner with B.Grimm Pharma to promote access to quality medications in Cambodia. Inter Mohosot will leverage its expertise and network to complement B.Grimm Pharma’s longstanding commitment to product quality, ultimately improving healthcare opportunities for Cambodian citizens.”
B.Grimm Pharma and Inter Mohosot aim to ensure widespread availability of quality medications for patients in Cambodia. With the combined strengths of both organizations, they will provide modern healthcare solutions to enhance access to quality treatments effectively and efficiently. With significant growth potential in the Cambodian healthcare market, both companies are well-positioned to meet local demands effectively. Through the shared values of quality and integrity, B.Grimm Pharma and Inter Mohosot aim to improve patient outcomes and drive meaningful change in the healthcare landscape.
This partnership not only signifies a business opportunity but also a shared commitment to genuinely improve the quality of life for people in Cambodia. B.Grimm Pharma is dedicated to developing new innovations while ensuring the best-in-class manufacturing quality standards, ensuring everyone can access essential medications and healthcare products to enhance their quality of life.
